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Abstract

Thomas W. O’Kane
THE MANY FACES OF SCHIZOPHRENIA RISK: CAN MEASURES OF RISK BE
AGGREGATED?
2020-2021
Dustin Fife, Ph.D, and Thomas Dinzeo, Ph.D
Master of Arts in Clinical Psychology

There are currently many different conceptualizations of schizophrenia risk,
which we argue is detrimental to any efforts to build a cumulative science in this area.
This paper sought to evaluate various conceptualizations of schizophrenia risk and the
extent to which they overlap. This paper attempts to identify overlap by utilizing metaanalytic methods in conjunction with data collected from a sample of undergraduate
college students (n = 80). To do so, we first collected estimates of various schizophrenia
risk measures and risk correlates from the literature. These estimates were subsequently
combined with collected data. This paper attempted to analyze review data and collected
data using meta-analytic structural equation modeling (MASEM) in a novel way.
Analysis of our collected data provided support for a hybrid model where risk subscales
loaded onto symptom clusters and two risk measures (SPQ-BR and O-LIFE) captured
unique variance. Overall, our results appear to support a movement towards consolidating
the fragmented risk literature and identified specific risk measures which may be
candidates for consolidation. Future research in this area may expand data collection
efforts and examine risk measures at an item level with the ultimate goal of developing a
novel risk measure which incorporates pre-existing measures.
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Chapter 1
Introduction
Schizophrenia is one of the leading causes of disability worldwide (Vos et al.,
2017) and is associated with premature mortality (Olfson, Gerhard, Huang, Crystal, &
Stroup, 2015) as well as increased unemployment rates (Bouwmans, De Sonneville,
Mulder, & Hakkaart-van Roijen, 2015) and medical comorbidities (Bahorik, Satre, KlineSimon, Weisner, & Campbell, 2017; Weber, Cowan, Millikan, & Niebuhr, 2009).
Furthermore, a review from Knapp, Mangalore, & Simon (2004) suggested schizophrenia
costs the United States around $32.5 billion in 1990, which would equate to roughly
$64.6 billion today. One of the best ways to reduce the societal burden of schizophrenia,
and its associated impairments, may be through identifying individuals at-risk for
psychosis to provide targeted prevention (Faraone, Brown, Glatt, & Tsuang, 2002;
Hutton & Taylor, 2013). Previous research demonstrated that prevention efforts can help
reduce the risk of developing psychosis, as well as mitigate symptomology (Hutton &
Taylor, 2013).
In order to develop effective prevention programs, individuals at risk for
transitioning to a schizophrenia-spectrum disorder must first be accurately and reliably
identified. Unfortunately, current risk assessment tools are limited in their predictive
utility and frequently fail to identify which individuals transition to a schizophreniaspectrum disorder (Tandon, Shah, Keshavan, & Tandon, 2012). A likely contributor to
inaccuracy in identifying who will transition to a schizophrenia-spectrum disorder is the
lack of consensus over what constitutes “risk”. There are many groups of risk researchers
with similar research goals operating under different paradigms. For example, there are
adherents to Meehl’s original schizotypy conceptualization (early 1960’s) that contrast
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with more recent schizotypy conceptualizations (e.g., Multidimensional Schizotypy;
Gross, Kwapil, Raulin, Silvia, & Barrantes-Vidal, 2018; Vollema & Van Den Bosch,
1995). Certain models avoid the term schizotypy all-together and emphasize ‘attenuated
symptoms’ such as psychosis proneness, psychotic-like experiences, clinical-high-risk
(CHR), and ultra-high-risk (UHR). While there may be some theoretical differences
between these different conceptualizations, different camps often use terminology
interchangeably (Kwapil & Barrantes-Vidal, 2015; Tandon et al., 2012). If possible, a
consolidation of these various risk conceptualizations would likely improve the efficacy
of risk identification, improve our ability to accurately identify which at-risk individuals
will transition, and strengthen our theoretical/etiological models for schizophrenia and
related disorders.
In the following paragraphs we will explore the benefits of a more cumulative and
synthesized view of risk for psychosis, as well as discuss a few of the major
conceptualizations for risk in the literature. Following that, we will describe common
correlates of risk indicators, then propose a methodology for consolidating these various
camps of research, ultimately aiding to construct a more cumulative science.
Cumulative Science: The Road to Risk Identification?
Investigators from these divergent psychosis-risk ‘camps’ frequently conduct
similar forms of research, with similar aims. For example, researchers working under the
frameworks of schizotypy and clinical high-risk both conduct research on how risk for
psychosis relates to social functioning (Addington, Penn, Woods, Addington, & Perkins,
2008; Henry, Bailey, & Rendell, 2008). Similarly, researchers examining schizotypy and
psychotic-like experiences both consider the possible association of cannabis use with
2

symptom presentation and severity (Stewart, Cohen, & Copeland, 2010; Van Gastel,
Kahn, & Boks, 2013). However, the evaluation of important phenomena under diverse
conceptualizations is inefficient and works against building a cohesive foundation of
knowledge. If there were a unified conceptualization, using the same measures and same
theoretical underpinnings, it would be easier for researchers to expand and refine each
other’s work. This would accelerate the development of an extensive risk literature and
contribute to greater advances in risk identification, so long as this unification does not
exclude important phenomena or oversimplify the risk construct. Indeed, as noted by
Henriques (2003) psychology cannot reach maturity as a science without shared
theoretical underpinnings.
Unfortunately, combining these divergent conceptualizations is not an easy task.
For example, it is unclear how these overlapping conceptualizations may best be
combined with regards to predictive value and theoretical underpinnings. Ideally, there
would be some way to study the existing research literature and incorporate past findings
despite the different constructs of psychosis risk that were employed. However, to create
the necessary links between the fragmented data within the literature there would need to
be available studies that directly compare the assessment measures/indices of interest. Of
course, researchers could begin anew (e.g., the proposed Research Domain Criteria
(RDoC) system; Insel et al., 2010), collecting large amounts of data from participants
across multiple biological and psychosocial levels. Unfortunately, this option is
inefficient and will likely take decades to bear fruit. Fortunately, we propose novel
quantitative methodology which will provide a powerful ‘hybrid’ solution where archival
research can be combined with contemporary data collection to synthesize insights
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gleaned from the existing divergent camps regarding risk. Before we speak of these
approaches, we review a few of these various risk conceptualizations.
Risk Conceptualization Frameworks
Schizotypy
In his seminal work, Meehl (1962) used the terms schizotaxia and schizotypy to
describe risk. Schizotaxia referred to an individual’s genetic predisposition towards
developing schizophrenia. On the other hand, schizotypy refers to behaviors (or other
phenomena) that reflect a presumed genetic/biological predisposition toward developing
schizophrenia interacting with environmental risk factors. Schizotypy remains a useful
term to describe a set of risk indicators (i.e., specific behaviors, cognitive-perceptual
experiences, etc.) which can be targeted for intervention. Even when using the common
term of schizotypy, researchers often conceptualize risk differently. Raine (1994) based
his conceptualization of schizotypy on the criteria for schizotypal personality disorder
seen in the DSM-III, to create the Schizotypal Personality Questionnaire (SPQ). This
conceptualization includes nine major sub-scales: Ideas of Reference, Excessive Social
Anxiety, Odd Beliefs or Magical Thinking, Unusual Perceptual Experiences, Odd or
Eccentric Behavior, No Close Friends, Odd Speech, Constricted Affect, and
Suspiciousness (Raine, 1991). The revised version (SPQ-BR) developed by Cohen,
Matthews, Najolia, and Brown (2010) also traces its roots back to the DSM criteria.
While there are many differences between these conceptualizations, most agree
schizotypy includes clusters of positive, negative, and disorganized symptoms (Cohen et
al., 2010; Gross, Kwapil, Raulin, Silvia, & Barrantes-Vidal, 2018; Kwapil et al., 2008a)
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and that schizotypy is associated with risk for developing schizophrenia (Horan, Reise,
Subotnik, Ventura, & Nuechterlein, 2008; Meehl, 1990).
Most commonly, theorists view schizotypy on a spectrum of symptoms, ranging
from those who theoretically exhibit no/few symptoms (a subclinical population) to those
with a schizophrenia-spectrum diagnosis (see Kwapil & Barrantes-Vidal, 2015 for a
breakdown of the spectrum). However, Meehl and his contemporaries (e.g.,
Lenzenweger, 2006) believe that there is a qualitative, or taxonic, model of risk where
schizophrenia represents a phenotype which emerges only at the highest level of risk
(Lenzenweger, 2006b; Meehl, 1962). However, even the theorists that view risk on a
continuum have devised ways of identifying those at the far end of the continuum for
special consideration (e.g., psychometrically defined schizotypy; Cohen & Najolia,
2011). Still, of all the risk conceptualization discussed in this paper, the dimensional view
of schizotypy attempts to capture the widest range of risk indicators, allowing for usage
in non-clinical populations (see Figure 1).
Psychosis Proneness
Another common conceptualization for risk uses terminology such as “psychosis
proneness” and “psychotic-like experiences.” These terms typically refer to an
individual’s predisposition to developing psychosis (or a schizophrenia-spectrum
diagnosis) and is composed of subscales measuring magical ideation (positive), social
anhedonia (negative), physical anhedonia (negative), and perceptual aberration (positive)
(Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994). Of note, psychosis proneness
and psychotic-like experiences were historically studied in participants with an identified
family member diagnosed with schizophrenia, although more contemporary research has
5

shifted to discerning ‘traits’ that can be identified even in the absence of a definitive
family history (Chapman et al., 1994). On the risk spectrum, psychotic-like experiences
and psychosis proneness would likely overlap heavily with schizotypy (see Figure 1). For
example, one item on the SPQ-BR asks “Do you believe in telepathy (mind-reading?)”
while another asks “Have you ever felt that you are communicating with another person
telepathically (by mind-reading)?” (Cohen et al., 2010). The Magical Ideation scale of the
Wisconsin Schizotypy Scales (Winterstein et al., 2011) covers similar content, with true
or false items such as “I have sometimes felt that strangers were reading my mind.”
Similar content can be found within the O-LIFE (Mason et al., 1995) and MSSB (Gross,
Kwapil, Raulin, et al., 2018) as well, with the O-LIFE asking “Do you think that you
could learn to read other’s minds if you wanted to?” and the MSSB contains a true or
false item stating “I have sometimes felt that strangers were reading my mind.” This
example extends to the PQ-B (Loewy et al., 2011), which asks “Have you had
experiences with telepathy, psychic forces, or fortune telling?” Given the high degree of
overlap between these conceptualizations and their measures, there may be ample room
to synthesize these conceptualizations.
Clinical/Ultra-High-Risk
An additional conceptualization of risk uses the terminology “clinical-high-risk”
(CHR) and “ultra-high-risk” (UHR) for psychosis/schizophrenia. CHR and UHR are
usually determined by exceeding a particular score on various risk measures. For
example, CHR individuals must present either attenuated positive symptoms, a brief
limited intermittent psychotic episode, or genetic risk with a decline in psychosocial
functioning (Fusar-Poli et al., 2013). An interesting development within this area of
6

research is the development of risk calculators to predict transition to psychosis (Cannon
et al., 2016; Fusar-Poli et al., 2019). Those calculators can, given certain information,
such as age; family history of psychosis; and trauma history, predict the probability of
experiencing psychosis. However, current risk calculators are limited in that they require
the individual to have already been identified through a mental health care system,
greatly limiting their ability for early identification and prevention. On the schizophreniaspectrum, CHR and UHR would likely fall closer to schizophrenia than psychotic-like
experiences, psychosis proneness, and schizotypy (see Figure 1).

Figure 1
The Schizophrenia-Spectrum

Clearly, there are many different conceptualizations and measures of risk for
schizophrenia. In fact, Mason (2015) identified over 20 measures of schizotypy (Mason,
2015). Since Mason’s (2015) review, more schizotypy scales have been developed, only
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adding to that number (Kwapil et al., 2018). That number also does not include all risk
measurements for schizophrenia, only those tied to schizotypy. This can be a problem, as
this can lead to the fragmentation of an already relatively niche literature. Further, having
researchers conduct studies looking at risk with different definitions can greatly impede
any effort to build a cumulative science within this area and improve progress in more
effectively identifying those at risk for schizophrenia.
Risk Correlates
Ideally, various studies utilizing risk instruments would measure risk using
multiple scales in the same study (e.g., SPQ-BR and Chapman Scales). This would make
it much easier to consolidate those various risk measures as we would be able to use
meta-analytic methods (e.g., meta-analytic structural equation modeling, or MASEM) to
aggregate across those studies. Unfortunately, researchers rarely utilize multiple
measures of risk as they frequently work exclusively within their framework. This makes
it difficult to utilize meta-analytic methods.
However, researchers often measure common correlates of risk. For example,
researchers frequently examine quality of life (Cohen & Davis, 2009; Fusar-Poli et al.,
2015), social functioning (Henry et al., 2008; Raghavan, Ramamurthy, & Rangaswamy,
2017), and stress (Dinzeo, Cohen, Nienow, & Docherty, 2004; Pruessner, Iyer, Faridi,
Joober, & Malla, 2011). These associations may help consolidate these various camps as
they provide a validity anchor from one study to the next. For example, if one study
investigates schizotypy and quality of life, while another studies UHR and quality of life,
the common variable (quality of life) may provide insights into how these two measures
(schizotypy and UHR) are associated. This additional information may be particularly
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valuable when considering how infrequently multiple conceptualizations of risk are
studied within the same study. In cases where those direct links between camps are
absent, we may be able to utilize risk correlates as an indirect link between camps.
A few (of many) correlates of risk include quality of life (QOL; Cohen & Davis,
2009; Fusar-Poli et al., 2015), social functioning (Henry et al., 2008; Raghavan et al.,
2017), and stress (Dinzeo et al., 2004; Pruessner et al., 2011). QOL refers to an
individual’s satisfaction with their life, as well as more objective indicators such as their
socioeconomic status (Cohen & Davis, 2009). QOL has often been linked to risk, with
lower QOL frequently being associated with higher levels of risk (Addington et al., 2008;
Cohen & Davis, 2009; Horan, Blanchard, Clark, & Green, 2008). Social functioning
represents another important construct relevant to risk as both an environmental predictor
and outcome. Social functioning is frequently characterized by difficulties interacting
with others, lack of social support, and an inability to form close relationships
(Birchwood, Smith, Cochrane, Wetton, & Copestake, 1990). It is well documented that
impairments to social functioning have been associated with schizophrenia-spectrum
symptoms (Addington et al., 2008; Kwapil, Barrantes-Vidal, & Silvia, 2008b).
Stress is an additional variable of interest to risk, as both a predictor and outcome.
One of the most widely utilized etiological theories regarding the development of
schizophrenia is the diathesis-stress model (Fowles, 1992). The diathesis-stress model
posits stress is closely linked to the development of schizophrenia. For example, higher
levels of stress and stress reactivity are frequently associated with greater risk (Dinzeo et
al., 2004; Myin-Germeys, Delespaul, & van Os, 2005; Van Os, Linscott, Myin-Germeys,
Delespaul, & Krabbendam, 2009). Previous research in this area suggests a bidirectional
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relationship between physiological/psychological stress sensitivity and risk, particularly
after encountering stressful life events (Grattan & Linscott, 2019).
In the present study, we sought to systematically and quantitatively review the
existing risk literature for schizophrenia/psychosis. Specifically, we were interested in
gathering estimates of various risk measures’ associations with one another, as well as
other important constructs such as quality of life (QOL), social functioning, and stress.
By gathering these estimates, we believe that we will take ‘the first step’ towards
synthesizing the various schizophrenia-risk conceptualizations. The ultimate synthesis of
these data may involve several additional steps, but it will be useful to first provide
insights which will guide further refinement.
Quantitative Literature Reviews
Earlier, we discussed the value of archivally consolidating the divergent risk
conceptualizations. Unfortunately, this would historically prove to be a Herculean task.
While meta-analysis is typically used to aggregate the same estimates across studies, it is
not ideal for situations where researchers investigate different variables. MASEM is
better suited for this task. One MASEM approach, called the multivariate two-stage SEM
uses a mixed model approach. Under this approach, MASEM handles instances where a
correlation from a particular study is missing by estimating the average (fixed effect)
correlation. For example, one study might not measure and report the correlation between
the SPQ-BR and UHR status. MASEM estimates this missing correlation by borrowing
information from each individual study.
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However, a major limitation of MASEM is that it cannot handle situations where
specific pairwise correlations are missing from all studies. For example, if no study ever
measured risk using both SPQ-BR and the Chapman scales, MASEM will report an error.
One suggested approach to handling this is to set the missing correlations to zero (e.g.,
Jak, 2015). This approach is problematic because it may bias parameter estimates toward
zero. To avoid this problem, the authors of the current paper will utilize a quantitative
literature review (QLR) methodology. Rather than setting missing correlations to zero,
this method utilizes a multiple imputation approach. When correlations are missing from
all studies under investigation, QLRs impute the missing values temporarily using
noninformative Bayesian priors, estimate the model’s parameters, then update the
estimates based on the newly updated model. As such, a multiple imputation approach
does not bias parameter estimates in the same way as if one were to set correlations to
zero (Furlow & Beretvas, 2010).
QLRs provide an ideal tool to handle entirely absent correlations in our attempt to
consolidate risk literature since correlations between risk measures from the various
frameworks are frequently missing. However, the number of missing correlations may be
quite extreme, and it is unclear if QLR methodology will produce meaningful estimates.
To evaluate this, we will compare the estimates generated by the QLR to estimates
gathered from newly collected data. Not only will the QLR-generated estimates increase
the precision of the data-generated estimates, but the data-generated estimates will
provide a validity check of the adequacy of the QLR algorithm. Hand in hand, we hope
the two will provide converging evidence across multiple methodologies.
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In summary, the purpose of this project is two-fold: first, we attempt to identify
whether the various risk frameworks can be consolidated into one cohesive schizophrenia
risk conceptualization. Our second purpose is to evaluate QLR’s ability to estimate
intercorrelations in the presence of a large quantity of missing correlations. Because this
research is primarily exploratory in nature, we have few specific hypotheses. Rather, we
will use the data to inform our research questions (and vice versa; see Fife & Rodgers,
2019).
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Chapter 2
Method
Literature Review
The present study began by collecting bivariate estimates of relationships between
various risk measures, prediction of transition to psychosis, and other relevant indicators
of functioning such as quality of life (QOL), stress, and social functioning. Descriptive
statistics for the estimates gathered from our review can be found in Table 1 (Note that
Table 1 only reports statistics for the global scales to save space. When performing the
QLR, we intend to utilize the subscales).
Under the consultation of a librarian, we systematically searched PsychINFO,
Pubmed, and Google Scholar for articles related to schizophrenia risk (see Appendix for a
list and description of studies included in the review). The following terms were used in
our search of the literature: “schizotypy”, “ultra-high-risk for psychosis”, “clinical highrisk for psychosis”, “schizophrenia”, “psychosis”, “schizotypal symptoms”, “quality of
life”, “QOL”, “well-being”, “social functioning”, “SPQ-BR”, “SPQ”, “O-LIFE”,
“MSSB”, “PSS”, “Chapman Scales”, “Wisconsin Schizotypy Scales”, “PQ-B”, “SFS”,
and “stress”. Various combinations of those terms were used as well, such as “schizotypy
and quality of life” or “schizotypy and prediction of schizophrenia.” For a study to be
included in this review, the authors had to report at least one measure of a bivariate
relationship (e.g., correlation coefficients, Cohen’s d, etc.) for any two of the variables in
which we were interested. If multiple articles used the same dataset for their analyses, we
chose to include the article which contained more estimates.
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Table 1
Estimates Included in QLR
Variable

O-LIFE

O-LIFE

7; (-0.02, .50)

Chapman Scales
QOL

Chapman Scales

QOL

SPQ-B

SF

(0.01, 0.82)

4

(-0.58, -0.38)
2

Stress
(0.05, 0.45)

(0.23, 0.29)

2

(-0.67, 0.57)

(-0.31, -0.05)

SPQ-B

(0.27, 0.56)

14

MSS/MSSB

2

SF
Stress

MSS/MSSB

(-0.45, -0.21)
4; (0.16, 0.73)

SPQ

SPQ

1
1

3; (0.08, 0.44)

1

3

Note. Correlation ranges reported represent associations between and within subscales. Numbers below diagonal represent the number
of studies which reported that relationship. Numbers above the diagonal denote the range of the subscale correlations of the reported
estimates for that relationship, or the range of correlations reported if multiple estimates were found. Psychotic-like experiences is not
included because common measures do not explicitly have subscales, our QLR requires subscales.

Data Collection Procedures
We collected data from 80 students at a mid-sized university in the northeastern
United States. Our sample predominantly identified as female (n=42), followed by male
(n=37) and other (non-binary; n=1), with a mean age of 19.43 (SD=1.78). The majority
of our sample identified as White (non-Hispanic; n=54), followed by Black (n=10),
Hispanic/Latinx (n=6), Asian/Pacific Islander (n=4), and other (multi-racial, Indian; n=6).
All procedures and methods were approved by the relevant IRB. To be eligible for
participation participants had to be at least 18 years of age. Data were collected online
through the university’s psychology participant pool.
Participants who scored above a predetermined cutoff point on a screener measure
(PQ-B) were contacted to arrange a follow-up interview (described in more detail below).
Of the 9 participants contacted, none responded to arrange the follow-up interview. This
poor follow-up rate was likely due to multiple factors, including “zoom fatigue”
experienced by many students during the COVID-19 pandemic, as well as follow-up
study not offering credit for students’ essentials psychology course. Due to this low
follow-up rate, the follow-up interview component of data collection will be prioritized
for a future research project.
Measures
Schizotypy and Psychosis Proneness
We utilized the following measures of schizotypy within our data collection:
Schizotypal Personality Questionnaire Brief-Revised (SPQ-BR; Cohen et al., 2010),
Oxford Liverpool Inventory of Feelings and Experiences-short scales (O-LIFE; Mason,
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Linney, & Claridge, 2005), and Multidimensional Schizotypy Scale-Brief (MSSB; (Gross
et al., 2018). The SPQ-BR is a 32-item measure of schizotypy with αs ranging from 0.870.94 across factor scores (Callaway, Cohen, Matthews, & Dinzeo, 2014; Cohen et al.,
2010). The SPQ-BR consists of three to four subscales, cognitive-perceptual (α = 0.94),
no close friends/constricted affect (α = 0.87), social anxiety (α = 0.90), and
disorganization (α= 0.92; Callaway et al., 2014; Cohen et al., 2010). The O-LIFE is a 43item measure of schizotypy with αs ranging from 0.62-0.80 across subscales (Mason et
al., 2005). The O-LIFE consists of four subscales, unusual experiences (α = .80),
cognitive disorganization (α = 0.77), introvertive anhedonia (α = 0.62), and impulsive
nonconformity (α = 0.63; Mason et al., 2005). The MSSB is a 38-item measure of
schizotypy with αs across two samples ranging from 0.78-0.90 across subscales (Gross et
al., 2018). The MSSB consists of three subscales, positive (α = 0.78, 0.80) negative (α =
0.80, 0.81), and disorganized (α = 0.90, 0.89; Gross et al., 2018). We will measure
psychosis proneness using the Wisconsin Schizotypy Scales (WSS; Winterstein et al.,
2011) consisting of the magical ideation (α = 0.74), perceptual aberration (α = 0.83),
social anhedonia (α = 0.75), and physical anhedonia (α = 0.62) (Winterstein et al., 2011).
The brief versions of the Wisconsin Schizotypy Scales contain a total of 60 items evenly
distributed among the 4 scales (Winterstein et al., 2011), with items from the WSS
originating from the Chapman Scales.
In total, we measured risk using 173 items (this number does not include items
assessing risk correlates). Clearly, administering such a large number of items may have
induced subject fatigue. To reduce potential bias due to the effects of fatigue, measures
were presented in a randomized order to participants. Due to the random order of our
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measures, any missing data in the study were considered missing completely at random,
meaning the missing data should not bias our estimates. Fortunately, only two individuals
partially completed measures.
Psychotic-Like Experiences and Ultra-High-Risk
To gather data on psychotic-like experiences and those at Ultra-High-Risk for
psychosis, the Prodromal Questionnaire-Brief was administered to all participants (PQ-B;
Loewy, Pearson, Vinogradov, Bearden, & Cannon, 2011). The PQ-B is a 21-item
measure which has been used to measure psychotic-like experiences as well as identify
individuals who may be at ultra-high-risk for psychosis (Ered, Cooper, & Ellman, 2018;
Loewy et al., 2011). The PQ-B has an α of 0.85 (Loewy et al., 2011).
Recall that a UHR diagnosis requires an interview, which can be time intensive.
Additionally, very few college students are likely to be considered UHR. For efficiency,
the PQ-B was used as a screener measure. Using a cutoff score of six, the PQ-B has
shown an ability to identify individuals at ultra-high-risk with 88% sensitivity and 68%
specificity (Loewy et al., 2011). Participants who scored above the cutoff point of six on
the measure’s distress score were contacted to arrange a follow up interview. This follow
up interview consisted of the Structured Interview for Prodromal Syndromes (SIPS;
Miller et al., 2003) to determine UHR status and was conducted by a research assistant
who was trained and certified to administer the interview.
The PQ-B does not contain subscales (or at least they are not reported in the
literature). While the items themselves could presumably be separated into subscales
(e.g., positive, negative, disorganized), it is impossible to do so with archival data. It is
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critical for our QLR analysis to have subscales, because having the subscales allows us to
determine whether certain subscales measure the same latent constructs (e.g., the positive
subscale of the SPQ and the positive subscale of the Chapman scale). Because no studies
report subscale estimates for PQ-B, this measure was not included in our QLR analysis.
However, upon collecting data, we were able to identify subscales to include within our
models. As a result, the PQ-B was not included in our QLR but was included in our data
collection analysis, where it was identified to have items measuring positive symptoms
and disorganized symptoms.
Risk Correlates
The following measures of common risk correlates were included in our data
collection: Perceived Stress Scale (PSS; Cohen, Kamarck, & Mermelstein, 1983), Social
Functioning Scale (SFS; Birchwood et al., 1990), Short Form 36-item Health Survey (SF36; McHorney, Ware, & Raczek, 1993; Ware & Sherbourne, 1992), and a modified
version of the Brief Quality of Life Interview (QOLI; Lehman, Kernan, Postrado, 1995).
The PSS is a 14-item measure of stress which has demonstrated adequate reliability, with
α scores ranging from 0.84-0.86 across three separate samples (Cohen et al., 1983). The
SFS is an 81-item measure of social functioning which has demonstrated acceptable
reliability, with α scores ranging from 0.69-0.87 across subscales (Birchwood et al.,
1990). The SFS consists of seven subscales, withdrawal (α = 0.72), interpersonal (α =
0.71), prosocial (α = 0.82), recreation (α = 0.69), independence-competence (α = 0.87),
independence-performance (α = 0.85), and employment occupation (Birchwood et al.,
1990). For this study, 9 items from the SFS covering interpersonal communication and
social engagement were used. The SF-36 is a 36-item measure of quality of life which
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has demonstrated adequate reliability, with α scores ranging from 0.75-0.92 across
subscales (McHorney, Ware, Rachel Lu, & Sherbourne, 1994). The SF-36 consists of
eight subscales, physical functioning (α = 0.92), role limitation due to physical health
problems (α = 0.87), bodily pain (α = 0.82), general health perceptions (α = 0.78), vitality
(α = 0.85), social functioning (α = 0.78), role limitations due to emotional problems (α =
0.75), and mental health (α = 0.80; McHorney et al., 1994). To measure quality of life,
we utilized the brief version of Lehman’s QOLI (Lehman, Kernan, Postrado, 1995). This
version contains 43 total items measuring subjective and objective QOL. The QOLI has
demonstrated mostly acceptable reliability with a α score range of 0.79-0.84 for
subjective QOL and a α score range of 0.44-0.82, for the subdomains of objective QOL
(Lehman, 1996).
Social Desirability
To address concerns of social desirability on participant responding, the MarlowCrowne Social Desirability Scale Brief Form XI (MCSDSB; Fischer & Fick, 1993;
Strahan & Gerbasi, 1972) was utilized. The MCSDSB is a self-report scale consisting of
10 items answered true or false with an α of .79 (Fischer & Fick, 1993).
Demographics
We collected data on participants’ demographic characteristics. Demographics in
which we were interested included: age, gender, race/ethnicity, and family mental health
history as well as whether the participant had sought mental health treatment before.
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Chapter 3
Data Analytic Plan
QLR
The QLR algorithm requires correlation matrices from each study collected. Once
obtained, these matrices were entered as inputs into the qlr package in R (Fife, 2020).
This algorithm, which is based on multivariate two-stage structural equation modeling
(TSSEM; Jak, 2015) strings out the correlations in column format (i.e., one column per
pairwise correlation). In our case, this yielded a matrix of 666 columns (e.g., QLife/Chapman, O-Life/QOL, Chapman/QOL, etc.) and 26 rows (one row per study).
Once in column format, the algorithm identifies columns where some (but not all)
correlations are missing. It then uses the completed columns to impute with multiple
imputation t the missing correlations. For those columns where all correlations are
missing (e.g., the SPQ/O-Life relationship), the algorithm then inputs noninformative
Bayesian priors (in this case, random values from a beta distribution with shape
parameters of four and four, which yields a distribution with mass centered on zero and
lower probabilities for high correlations). At this point in the algorithm, the entire 666 by
26 matrix is complete, with mostly imputed values. Once this is done, the matrix is
converted back into a symmetric (correlation) matrix by taking the average of each
column, then the algorithm fits the two structural equation models. Finally, the algorithm
repeats this process 1,000 times, generating 1,000 fitted SEMs. These fitted SEMs will
each have different parameter estimates (e.g., factor loadings, residual variances), each of
which constitutes a sample from the posterior distribution.
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Additionally, at each of the 1,000 iterations, we will fit two different confirmatory
factor analysis models. One of those models, called “Measure-Based Model,” assumes
every measure of risk is a unique latent variable (though each measure is allowed to
correlate with the others). For this model, all subscales are treated as indicator variables.
(See Figure 2).

Figure 2
Path Diagram of Measure-Based Model

Note. Boxes represent observed variables, circles represent latent variables. This model
theorizes that each measure of risk captures distinct latent variables. Not all included
measures are pictured. Measures of risk correlates not included as they are not critical to
the SEM; they are solely being used to estimate missing correlations. O-LIFE is not
included for sake of visual complexity. SA = Social Anhedonia; MI = Magical Ideation
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The other model, “Symptom-Based Model,” also treats the subscales of each
measure as an indicator of risk, but these subscales load onto common latent variables.
The latent variables we proposed include Positive, Negative, and Disorganized. See
Figure 3 for a path diagram.

Figure 3
Path Diagram of Symptom-Based Model

Note. Boxes represent observed variables, circles represent latent variables. This model
theorizes that each measure’s subscales will load into common latent variables.

Ideally, the algorithm will yield 1,000 unique fitted models. However, there is the
possibility the algorithm will fail to converge on some (or many) of these iterations. If it
fails to converge, parameter estimates cannot be trusted. Also, fit indices will not be
computed. For those occasions where the algorithm does converge, we will record
parameter estimates and fit indices. Provided there are enough occasions of convergence,
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we will be able to estimate distributions of fit indices, which represent samples from a
posterior distribution. In this case, we will utilize the distribution of fit indices to
determine which model fits better. For example, if 95% of RMSEA values fit better for
one model over another, we would favor that model. The same will be held true for other
measures of fit.
Naturally, both models required modifications, as this analysis was partially
exploratory in that no prior study has examined similar models (see Fife & Rodgers,
2020). Modifications were driven by theory, modification indices, and residual analysis,
culminating in a third model, the “Modified Model.” The process of creating this
modified model occurred after our other analyses.
In addition to estimating fit indices, we also recorded parameter estimates from
the models (factor loadings, variance explained, regression weights for outcomes). To
determine whether QLR is able to estimate valuable information from such a sparse
matrix, we identified whether the standardized estimates span the entire range of
potential values (i.e., approximately -1 to +1 for factor loadings/regression weights, and 0
to +1 for variance explained). If they did span the entire range (or closely span the entire
range), the QLR was essentially useless. It is possible that some estimates span the entire
range (e.g., a factor loading for the Disorganized latent variable), while others do not. As
such, we identified which factor loadings were informative.
Data Collection Analysis
Similar to our analysis in the previous step, we utilized the actual data to fit the
three models (Measure-Based, Symptom-Based, and Modified) using the lavaan
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package in R (Rosseel et al., 2020). We assessed fit for each model using global and local
fit indices, residual analysis, as well as visual indicators (utilizing the R package
flexplavaan; Fife et al., 2021a; Fife et al., 2021). To further determine the utility of
QLR, we identified whether the actual estimates obtained from data collection fell within
the 95% credible intervals from the QLR analysis. Once again, it is possible that some
estimates fell within the range of the credible intervals, while others do not. We report the
proportion that do.
QLR and Data Analysis
QLR was developed with the intention of providing a means of generating priors
for Bayesian-based hypotheses. As such, the initial QLR analysis allowed us to integrate
the archival data from the literature with new data we collected. To accomplish this, we
used the posterior estimates from the QLR analysis as priors for the actual data analysis.
These priors were combined with the data to, hopefully, increase the precision of the
model’s parameter estimates. To do so, we utilized the blavaan (Merkle & Rosseel,
2018) package in R. We compared these Bayesian estimates to those obtained from the
QLR alone (first analysis) and the uninformed data analysis (second analysis). Once
again, we expected the credible intervals for the QLR + Data Analysis (third analysis) to
be much narrower than the QLR alone analysis (first analysis) and at least marginally
narrower than the data alone analysis (second analysis).
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Chapter 4
Results
QLR Analysis
We attempted to fit structural equation models utilizing the estimates gathered
from our QLR. Unfortunately, the algorithm failed to converge on a solution in all but
four iterations (out of 1,000) of the model. Additionally, the estimates for the 1,000
iterations spanned the entire range of potential estimates (e.g., -1 to +1) meaning they
were largely uninformative. This result suggests that a correlation matrix as sparse as the
one generated by the present QLR (Table 1) will not produce meaningful estimates, in
spite of the missing data strategy employed. As a byproduct of our failed QLR analysis,
we were unable to complete the QLR analysis nor the combined QLR and data collection
analysis outlined in our data analytic plan. Further, because risk correlate data was
collected primarily with the purpose of facilitating a connection between the QLR and
data collection, our analyses did not include the risk correlates.
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Table 2
Means, Standard Deviations, and Reliability Estimates (n = 78-80)
Standard Deviation

Cronbach’s α

Measure

Mean

SPQ-BR Positive

33.73

12.13

0.92

SPQ-BR Negative

27.00

8.14

0.88

SPQ-BR Disorganized

18.52

6.08

0.87

MSSB Positive

2.09

2.86

0.86

MSSB Negative

2.08

2.28

0.74

MSSB Disorganized

2.67

3.73

0.93

WSS Physical Anhedonia

2.39

1.90

0.54

WSS Social Anhedonia

3.10

2.55

0.72

WSS Magical Ideation

2.72

2.90

0.79

WSS Perceptual Aberration

.99

2.72

0.94

O-LIFE UE

3.05

3.09

0.85

O-LIFE CD

4.95

3.59

0.87

O-LIFE IA

2.15

1.81

0.55

O-LIFE IN

2.95

1.91

0.47

PQ-B Total Score

4.89

5.26

0.89

PQ-B Distress Score

14.55

16.66

0.91

Data Collection Analysis
Demographic characteristics of our sample can be found in the data collection
procedures section of this paper, with mean, standard deviation, and reliability
information from the collected measures displayed in Table 2. To account for potential
social desirability effects on our sample, bivariate correlations between the MCSDSB and
our variables of interest were examined. Only one of these correlations (O-LIFE
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cognitive disorganization; r = -.23, p = .04) emerged as significant, suggesting it is
unlikely for social desirability to have influenced our results. As such, social desirability
effects were not controlled for in further analyses. Table 3 shows a correlation matrix of
the subscales.
Figures 4, 5, and 7 visualize a subset of each model’s fit using “trail plots” (Fife,
Brunwasser, & Merkle, 2021). The diagonals of trail plots show the histograms of
residuals for each variable. The red lines depict the SEM-implied fit between two
variables, while the blue lines depict the quadratic or regression line between those same
two variables. The closer the SEM-implied red line is to the quadratic or regression line,
the better the proposed SEM model fits. The upper triangle of the scatterplot matrices
shows the raw data, while the lower triangle displays a “disturbance-dependence plot,”
which shows the scatterplot after subtracting out the fit of the model.
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Table 3
Correlations Among Risk Measures
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Measure

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

1. SPQ-BR Positive

1

2. SPQ-BR Negative

0.65

1

3. SPQ-BR Disorganized

0.66

0.66

1

4. MSSB Positive

0.66

0.38

0.40

1

5. MSSB Negative

0.26

0.29

0.13

0.38

1

6. MSSB Disorganized

0.62

0.52

0.51

0.58

0.40

1

7. WSS Physical

-0.02

0.21

0.13

0.15

0.37

0.07

1

8. WSS Social
Anhedonia
9. WSS Magical Ideation
Anhedonia
10. WSS Perceptual

0.36

0.50

0.27

0.38

0.72

0.44

0.47

1

0.67

0.29

0.42

0.74

0.26

0.49

0.05

0.21

1

0.20

0.06

0.00

0.44

0.42

0.29

0.25

0.47

0.28

1

11. O-LIFE UE
Aberration
12. O-LIFE CD

0.75

0.55

0.54

0.76

0.36

0.72

0.14

0.44

0.65

0.27

1

0.57

0.61

0.64

0.46

0.14

0.73

0.16

0.36

0.39

0.17

0.66

1

13. O-LIFE IA

0.20

0.36

0.23

0.07

0.50

0.31

0.42

0.57

0.12

0.24

0.22

0.31

1

14. O-LIFE IN

0.40

0.25

0.29

0.34

0.35

0.53

0.12

0.29

0.29

0.36

0.51

0.42

0.19

1

15. PQ-B Total Distress

0.78

0.57

0.60

0.61

0.25

0.67

0.01

0.29

0.59

0.26

0.81

0.68

0.21

0.50

Figure 4
Symptom-Based Model Trail Plot

Note. Diagonals show the histograms of residuals for each variable. The red lines depict
the SEM-implied fit between two variables, while the blue lines depict the regression line
between those same two variables. The closer the SEM-implied red line is to the
quadratic line, the better the proposed SEM model fits. The scatterplot matrices show the
raw data.

For each trail plot, we chose to visualize the variables that showed the worst
misfit. The symptom-based model struggled most to fit the correlations between the SPQ-
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BR negative, SPQ-BR disorganized, SPQ-BR positive, O-LIFE unusual experiences, OLIFE cognitive disorganization, and MSSB disorganized variables. The trail plots of
these variables are shown in Figure 4. Notice that in nearly all cases, the model tended to
underestimate the correlations between these variables. This suggests that, at least for
SPQ-BR (as well as possibly the O-LIFE and MSSB), merely correlating the symptoms
does not entirely account for correlations between the subscales.
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Figure 5
Measure-Based Model Trail Plot

Note. Diagonals show the histograms of residuals for each variable. The red lines depict
the SEM-implied fit between two variables, while the blue lines depict the quadratic line
between those same two variables. The closer the SEM-implied red line is to the
quadratic line, the better the proposed SEM model fits. The scatterplot matrices show the
raw data.
The measure-based model struggled to reproduce correlations between O-LIFE
introvertive anhedonia, WSS social anhedonia, MSSB negative, WSS physical
anhedonia, WSS perceptual aberration, and SPQ-BR disorganized (see Figure 5). Notice
how each of these subscales measure the “Negative” latent variable from the symptom31

based model. This seems to suggest that a model based exclusively on the measure is
inadequate: it misses important information shared across measures. Also, these plots
seem to suggest that many of the subscales have nonlinear relationships (e.g., between
WSS social anhedonia and WSS physical anhedonia) that are not adequately represented
by a linear model.
These results seem to suggest that neither a symptom-based nor a measure-based
model is adequate: the symptom-based model underestimated correlations within
measures, while the symptom-based measure underestimated correlations across
measures. It seems the best-fitting model will combine the strengths of both models.
To identify a modified model, we began by studying the residuals for the
measure-based model. As noted previously, the correlations between various subscales
were underestimated in the measure-based model (i.e., O-LIFE introvertive anhedonia,
WSS social anhedonia, MSSB negative, and WSS physical anhedonia). Since each of
these measure negative symptoms, we created an additional latent variable (called
“Negative”), then refit the model. Once again, we studied the residuals, identifying which
correlations the model failed to reproduce, and again modified the model in such a way
that the model better captured the relationships. This process was repeated multiple times
until the residuals were small and the visuals suggested agreement between the implied
model and observed regression line.
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Figure 6
Path Diagram of the Proposed Modified Model

Note. Boxes represent observed variables, circles represent latent variables. The proposed
modified model suggests a hybrid model, where subscales load onto symptom clusters as
well as their overall measure in the case of the O-LIFE and SPQ-BR. It was assumed that
all latent variables in the model were correlated with each other.

The final proposed modified model is shown in Figure 6. This model suggests that
these measures all share three latent variables: Negative, Positive, and Disorganized.
However, the SPQ-BR and O-LIFE capture additional information that is not captured by
these latent variables. Figure 7 shows the trail plots of the three variables with the largest
residuals (WSS perceptual aberration, O-LIFE impulsive nonconformity, and MSSB
positive). In all cases, the observed slope (blue line) is quite similar to the model-implied
slope (red line), though the model-implied slope tends to be more conservative, while the
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observed slope seems to be more prone to influence from outliers (e.g., the WSS
perceptual aberration and O-LIFE impulsive nonconformity relationship relationship).
Also, the quadratic lines indicate the variables may have nonlinear relationships.

Figure 7
Modified Model Trail Plot

Note. Diagonals show the histograms of residuals for each variable. The red lines depict
the SEM-implied fit between two variables, while the blue lines depict the quadratic line
between those same two variables. The closer the SEM-implied red line is to the
quadratic line, the better the proposed SEM model fits. The scatterplot matrices show the
raw data.
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A collection of fit indices for the measure-based, symptom-based, and modified
models can be found in Table 4. Neither the symptom or measure-based model seems to
fit well, at least by conventional rules of thumb (Hu & Bentler, 1998; though see Hayduk,
2014; McIntosh, 2007 for arguments against rules of thumb in SEM). Even the modified
model appears to fit poorly (again, by conventional rules of thumb). The AIC and BIC
appear to favor the symptom-based model over the modified model, however the
RMSEA, SRMR, and CFI values favor the modified model. This would suggest that the
modified model provides a stronger fit to the data at the expense of added model
complexity. However, the best model combines aspects of both the symptom-based and
measure-based models. (Granted, the modified model benefited from post-hoc
modifications, while the other two models did not. As such, the fits associated with the
modified model have an unfair advantage).

Table 4
Data Collection SEM Model Estimates and Fit Indices (n=78)
Fit Indicator

Symptom-Based Model

Measure-Based Model

Modified Model

RMSEA

0.15

0.17

0.12

SRMR

0.13

0.12

0.082

AIC

5832.92

6196.89

6083.40

BIC

5910.70

6295.87

6196.53

CFI

0.78

0.74

0.88
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Table 5 shows the parameter estimates for the three models, with Figure 8
visualizing parameter factor loadings. With regards to the symptom-based model, the
following subscales had factor loadings over 0.7: SPQ-BR positive, SPQ-BR
disorganized, MSSB (all three subscales), O-LIFE unusual experiences, O-LIFE
cognitive disorganization, WSS social anhedonia, WSS magical ideation, PQ-B positive,
and PQ-B disorganized. Only two subscales had a factor loading of 0.5 or lower, WSS
physical anhedonia and WSS perceptual aberration. For the measure-based model, the
following subscales had factor loadings above 0.7: SPQ-BR (all three subscales), MSSB
positive, MSSB disorganized, O-LIFE unusual experiences, O-LIFE cognitive
disorganization, PQ-B positive, and PQ-B disorganized. Subscales with a factor loading
of 0.5 or lower were as follows: MSSB negative, O-LIFE introvertive anhedonia, WSS
perceptual aberration, and WSS physical anhedonia.
Looking at the modified model, subscales with a factor loading of above 0.7
included: SPQ-BR positive (when loading into the positive symptom variable), SPQ-BR
negative (when loading onto the SPQ-BR variable), MSSB (all three subscales), O-LIFE
cognitive disorganization (when loading onto the disorganized variable), WSS social
anhedonia, WSS magical ideation, PQ-B positive, and PQ-B disorganized. The following
subscales had a factor loading of 0.5 or less: SPQ-BR positive (when loading onto the
SPQ-BR variable), SPQ-BR negative (when loading onto the SPQ-BR negative variable),
SPQ-BR disorganized (when loading onto the disorganized variable), O-LIFE unusual
experiences (when loading onto the positive variable), O-LIFE cognitive disorganization
(when loading onto the O-LIFE variable), O-LIFE introvertive anhedonia (when loading
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onto the O-LIFE variable), and WSS perceptual aberration. Taken together, these results
suggest that neither of the original models is adequate: the symptom-based model has
higher correlations within subscales than the model suggests, while the measure-based
model underestimates correlations between subscales. In addition, both models show
evidence of nonlinear effects. As a whole, our data collection analysis appears to favor a
hybrid model, where each subscale loads onto a symptom cluster and two measures
(SPQ-BR and O-LIFE) seemingly capture unique risk variance. Additionally, our
analysis provides insight into which measures best tap into risk symptoms.
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Figure 8
Factor Loadings for the Symptom-Based, Measure-Based, and Modified Models
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Table 5
Parameter Estimates of the Symptom-Based, Measure-Based, and Modified Models
Variable

Factor Loadings

Variance Explained
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Symptom-

Measure-

Modified Model

Symptom-

Measure-

Modified

SPQ-BR Positive

0.85
Based
Model

0.91
Based
Model

0.33(SPQ)/0.81(Positive)

0.73
Based
Model

0.83
Based
Model

0.80
Model

SPQ-BR Negative

0.53

0.73

0.77(SPQ)/0.36(Negative)

0.28

0.53

0.83

SPQ-BR Disorganized

0.71

0.74

0.52(SPQ)/0.36(Disorganized)

0.50

0.55

0.63

MSSB Positive

0.79

0.79

0.81

0.63

0.62

0.65

MSSB Negative

0.76

0.50

0.77

0.58

0.24

0.59

MSSB Disorganized

0.83

0.75

0.82

0.69

0.55

0.67

O-LIFE UE

0.93

0.89

0.64(O-LIFE)/0.28(Positive)

0.86

0.80

0.84

O-LIFE CD

0.86

0.71

-1.24(O-LIFE)/2.09(Disorganized)

0.74

0.50

0.98

O-LIFE IA

0.63

0.28

-0.08(O-LIFE)/0.67(Negative)

0.49

0.08

0.39

O-LIFE IN

N/A

0.53

0.52

N/A

0.28

0.27

WSS Perceptual

0.34

0.39

0.36

0.11

0.15

0.13

WSS Physical
Aberration
WSS Social Anhedonia
Anhedonia
WSS Magical Ideation

0.50

0.15

0.51

0.25

0.02

0.26

0.93

0.54

0.93

0.83

0.29

0.87

0.73

0.68

0.75

0.53

0.46

0.56

PQ-B Positive

0.87

0.93

0.87

0.76

0.87

0.75

PQ-B Disorganized

0.77

0.74

0.74

0.60

0.55

0.55

Chapter 5
Discussion
The schizophrenia-spectrum literature currently consists of many different
theoretical camps conducting their own research separate of the others, much to the
detriment of any chances for the field to become a cumulative science. This study
examined the various measures of schizophrenia-spectrum risk used by these camps, as
well as common correlates of schizophrenia-spectrum risk. This was accomplished via a
quantitative literature review (QLR) as well as data collection.
There were two primary goals for this study. The first was to identify whether the
various risk frameworks can be synthesized into one cohesive schizophrenia risk
conceptualization. The second was to evaluate whether our QLR methodology would be
able to estimate intercorrelations in the presence of a large quantity of missing
correlations. We largely accomplished our first goal, with our analyses suggesting that it
may be fruitful to condense some of the various schizophrenia-spectrum measures. With
regards to our second goal, it is evident that our QLR methodology will not successfully
estimate intercorrelations when confronted with a large amount of missing data.
Implications for the schizophrenia-spectrum literature and quantitative literature are
discussed in greater detail in the following paragraphs.
The present study found slight support in favor of a symptom-based model (where
subscales of risk measures were proposed to load onto positive, negative, or disorganized
symptoms) compared to a measure-based model (which proposed that each risk measure
captured a unique element of overall risk). However, neither symptom nor measure-based
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models were adequate. A modified model, a hybrid model of sorts between the symptom
and measure-based models, provided the strongest fit of either of the three models to our
data, although at the price of added complexity in comparison to the symptom-based
model. Within this model, along with the symptom clusters, the SPQ-BR and O-LIFE
emerged as unique latent variables.
Our findings would appear to provide support to a movement towards
consolidating the various risk conceptualizations and accompanying measures employed
in the literature, as many of these differing measures do not appear to be capturing unique
variance. Based on our analysis, the SPQ-BR and O-LIFE are measures which capture
some unique element of risk variance, with the subscales of other measures loading onto
positive, negative, or disorganized symptoms. Measures included in this study such as the
WSS and MSSB may be candidate measures for future consolidation as they do not
appear to capture unique risk variance, although it should be noted that with an increased
sample size more measures may have been found to account for unique variance. Based
on factor loadings and variance explained metrics, the PQ-B, unusual experiences, and
cognitive disorganization subscales of the O-LIFE, as well as the negative subscale of the
MSSB are particularly promising measures of schizophrenia-spectrum risk symptom
clusters (e.g., positive, negative, and disorganized) to consider in any future
consolidation.
Of note, the present study found a trend in many of the risk measures. When
visualized, the relationships in the data were frequently curvilinear in nature, increasing
steadily until a threshold of sorts is reached, whereupon the relationship increases at a
steeper rate (see Figures 5 and 6 for examples). This may provide further support towards
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conceptualizing schizophrenia and schizophrenia risk as lying on a spectrum, where most
of the population experience some level of risk symptoms but only a subset may
experience schizotypy and even fewer experience schizophrenia (APA, 2013;
Lenzenweger, 2006a; Meehl, 1962). Alternatively, the curvilinearity may be an artifact of
distributional properties such as a floor effect in our data. These two explanations could
be re-examined in future research.
With regards to our proposed quantitative literature review (QLR) methodology,
the present study revealed grave limitations in the methodology when confronted with
significant missing data. When estimates between variables of researcher interest are
sparse in the literature, models produced by the QLR will frequently fail to converge. In
instances where the models do converge, the models will likely produce estimates
spanning the entire range of potential estimates, which are of minimal utility to
researchers. This represents a significant obstacle for attempts at consolidating the
archival risk literature. One potential solution for this may be to identify clusters, or
portions, of the entire model of interest that can be fit and informative, rather than
attempting to fit the entire model. This approach could allow researchers to use the QLR
methodology as intended, integrating archival information regarding risk measures and
risk correlates while attempting to consolidate the risk literature.
Perhaps the most straightforward approach to addressing this as a field is to more
frequently include multiple measures of risk in the same study. When this is done,
researchers should report the bivariate relationships between those measures and/or make
their dataset publicly available for other researchers in an effort to foster a consolidated,
cumulative science. These efforts may aid the field in building a cumulative science.
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Hopefully, once more evidence has been gathered (both from our efforts as well as efforts
of other researchers), we will have gathered enough evidence to form a comprehensive
view of schizophrenia risk. Subsequently, one measure may be developed that adequately
taps all relevant dimensions of schizophrenia without overlap. The importance of a
consolidated, cumulative risk literature cannot be overstated. To reiterate the sentiment
expressed by Henriques (2003), psychology cannot reach maturity as a science without
shared theoretical underpinnings. The schizophrenia-spectrum area of research is no
different, as currently the many different camps of risk research pull in separate
directions instead of together. While consolidation is not without its risks, such as the
potential for consolidation to oversimplify our understanding and assessment of risk, our
study appears to provide initial support in favor of consolidation.
Limitations
One major limitation of the present study is the sample. Our sample was
predominantly white and exclusively contained college students, potentially limiting
generalizability. That being said, college student samples can be useful for risk research
as the “typical” college student falls within an age range where development of
schizophrenia-spectrum symptoms is relatively common (NIMH, 2018). Additionally,
our small sample size (78 for the SEM analyses) may have impacted our ability to pick
up on notable trends in our data. As noted by (Kline, 2016 p. 14-16), to be adequately
powered SEM analyses typically require sample upwards of 200 participants or 20
participants per parameter estimated.
An additional limitation of the present study was the inability to include the UHR
and CHR conceptualizations of risk in our analysis due to poor follow-up rates. This
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limitation was partially mitigated by the presence of the PQ-B in our study, a measure
commonly used to screen for individuals who may meet UHR/CHR risk criteria (Loewy
et al., 2011).
Future Research
A seemingly obvious target for future research will be to successfully collect SIPS
data within the same dataset as other measures of risk, allowing for a more complete
comparison of the schizophrenia-spectrum risk conceptualizations. Additional future
research may seek to develop a novel risk measure (or set of measures) that consolidates
many of the risk measures evaluated in this study in an optimal way. This may take the
form of a factor analysis on item level data from a dataset where researchers administer
numerous risk measures to a large sample and identify the most consistently predictive
items. Such an undertaking may be considered “carving nature at its joints” (Meehl,
1999, p. 1) in an attempt to identify groupings of items which consistently predict risk for
developing a schizophrenia-spectrum disorder. As part of this undertaking, data on risk
correlates (e.g., QOL, stress, social functioning, etc.) may be collected to aid researchers
in understanding how measures of risk differentially correlate with various spheres of
daily functioning. This information may be important when attempting to consolidate the
risk literature in the form of developing a new risk measure. For example, researchers
may be interested in developing a risk measure that strongly correlates with a worse QOL
or greater impairment in social functioning.
An optimally consolidated risk measure may allow researchers from various risk
camps to consolidate their efforts and contribute to the building of a cumulative risk
literature. The most important potential byproduct of a novel, optimally consolidated risk
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measure would be an improved ability to detect those at risk for developing
schizophrenia-spectrum symptomology and allow for targeted prevention efforts. Such a
measure would likely have to be studied longitudinally to properly evaluate its
effectiveness at risk identification relative to other measures.
Conclusions
The schizophrenia-spectrum literature is currently divided into different
theoretical camps, potentially hampering any effort to build a cumulative science in this
area and ultimately harming prevention efforts. Our data indicate that many of the
schizophrenia-spectrum risk measures load onto latent variables organized by symptom
cluster, suggesting the potential for consolidation to take place without a meaningful loss
in measuring schizophrenia-spectrum risk. According to our analysis, the only measures
which captured unique variance were the SPQ-BR and O-LIFE, although future studies
which include a greater quantity of measures and utilize a larger sample may identify
more such measures. While much work remains to be done to consolidate the risk
literature effectively, this study offers an initial glimpse into a potential consolidation.
Future research may examine item-level data using factor analysis to develop a new risk
measure which integrates items from previous measures. Once developed, this measure
should be evaluated longitudinally to evaluate its effectiveness in accurately and
reliability predicting who is at risk for transitioning to a schizophrenia-spectrum disorder,
as well as establish that the measure has longitudinal invariance (meaning a stable factor
structure over time).
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Appendix

List and Description of Studies Included in QLR

Study

Sampl

Sample Characteristics

Variables Included

Kwapil et al., 2020

e9,366
Size

College students

MSS

Herzig et al., 2013

58

College students

O-LIFE, Stress

Wuthrich et al., 2006

277

College students

SPQ, Chapman scales

Gross et al., 2018*

1,430

College students, MTurk

MSSB, SPQ-B

Gross et al., 2018*

1,289

College students, MTurk

MSSB, SPQ-B

Abbott et al., 2012

139

College students

SPQ, QOL

Henry et al., 2008

223

Community volunteers, college students

SPQ, SF

Alexopoulos et al., 2014

201

Greek police officers

QOL, Stress

Panayiotou et al., 2013

326

Greek adults

QOL, Stress

Delgado, 2007

181

People with COPD

QOL, Stress

Cicero et al., 2014

160

College students at psychometric risk

Chapman scales

Meyer, 2001

70

Inpatient psychiatric unit patients

QOL, SF

Lin et al., 2013

228

Help-seeking research participants

QOL, O-LIFE

Cohen et al., 2009

1395

College students

QOL, SPQ

McCleery et al., 2012

50

College students

QOL, O-LIFE

Barragan et al., 2011

72

Adolescents in Spain

O-LIFE

Cicero et al., 2010

295

College students

Chapman scales

Lewandowski et al., 2006

1254

College students

Chapman scales

Batey et al., 2008

140

College students

O-LIFE

Rawlings et al., 2001

100

College students

O-LIFE

Premkumar et al., 2018

318

Primarily college students

O-LIFE, QOL

Note. * denotes a study which included multiple samples.
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